With a revenue increase of 55.45% in the first quarter 2025, year on year to cumulative value of $562 million, Blueprint Medicines's revenue per employee grew on a trailing twelve months basis to $ 965,844. The productivity of Blueprint Medicines's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 104 other companies have achieved higher revenue per employee. While Blueprint Medicines's total ranking has deteriorated compared to the previous quarter from 572 to 808. Blueprint Medicines has 582 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BPMC Revenue per Employee	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Revenue Change	55.45 %	88.19 %	126.61 %	139.98 %	67.25 %
Sales per Employee (TTM) $	965,844	874,268	756,414	633,359	494,893
BPMC's Total Ranking	# 808	# 572	# 445	# 362	# 620
Seq. Revenue Change	2.08 %	14.19 %	-7.22 %	43.74 %	23.58 %

BPMC Company Profile >> Back to BPMC Efficiency Comparisons >> Compare BPMC Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 60
Healthcare Sector	# 105
Overall Market	# 808

Revenue per Employee Statistics
High	Average	Low
$ 1,440,893	$ 452,190	$ -40,400
(Sep 30 2020)		(Jun 30 2019)

Financial Statements
Blueprint Medicines's Revenue MRQ	$ 149 Millions	Visit BPMC's Income Statement
Blueprint Medicines's Revenues TTM	$ 562 Millions	Visit BPMC's aggregate revenue growth
What are BPMC's Sales?		Visit BPMC's Sales by Segment

Other Ratios
Blueprint Medicines's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
BPMC's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for BPMC's Competitors
Revenue per Employee for BPMC's Suppliers
Revenue per Employee for BPMC's Customers

You may also want to know
BPMC's Sales Growth Rates	BPMC's Pe Price to earnings ratio	BPMC's Receivables Turnover Ratio	BPMC's Stock Quote
BPMC's Net Income Growth Rates	BPMC's Ps Price to Sales ratio	BPMC's Sales per Employee	BPMC's Asset Turnover Ratio
BPMC's Net Margin	BPMC's Pb Price to Book ratio	BPMC's Financial Strength Ratios	BPMC's Dividend Payout Ratio

Date modified: 2026-08-29T17:30:20+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2025, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2025	Number of Employees Mar 31 2025
Novavax inc	1,675,516.69	$ 1,254.962 Million	749
Semler Scientific inc	1,587,935.48	$ 49.226 Million	31
Protagonist Therapeutics inc	1,574,250.00	$ 207.801 Million	132
Collegium Pharmaceutical Inc	1,567,075.65	$ 662.873 Million	423
Incyte Corporation	1,551,767.23	$ 4,413.226 Million	2,844
Scilex Holding Company	1,491,470.59	$ 50.710 Million	34
Century Therapeutics inc	1,473,051.28	$ 114.898 Million	78
Privia Health Group Inc	1,469,203.92	$ 1,801.244 Million	1,226
Bristol myers Squibb Company	1,465,723.08	$ 47,636.000 Million	32,500
Evoke Pharma Inc	1,449,260.38	$ 11.594 Million	8
Progyny Inc	1,416,766.36	$ 1,212.752 Million	856
Jazz Pharmaceuticals Plc	1,406,507.96	$ 4,064.808 Million	2,890
Nektar Therapeutics	1,384,888.89	$ 87.248 Million	63
Coherus Oncology inc	1,343,510.20	$ 197.496 Million	147
Kiniksa Pharmaceuticals International Plc	1,314,661.20	$ 481.166 Million	366
Biogen Inc	1,308,853.33	$ 9,816.400 Million	7,500
Puma Biotechnology Inc	1,300,050.28	$ 232.709 Million	179
Arcturus Therapeutics Holdings Inc	1,294,414.41	$ 143.680 Million	111
Xenetic Biosciences Inc	1,291,364.00	$ 2.583 Million	2
Lantheus Holdings Inc	1,287,632.02	$ 1,536.145 Million	1,193
Elite Pharmaceuticals Inc	1,278,256.23	$ 83.087 Million	65
Avadel Pharmaceuticals Plc	1,260,506.49	$ 194.118 Million	154
Acadia Pharmaceuticals Inc	1,248,474.94	$ 996.283 Million	798
Agenus Inc	1,228,691.36	$ 99.524 Million	81
Whitehawk Therapeutics Inc	1,207,608.70	$ 27.775 Million	23
Neurocrine Biosciences Inc	1,206,300.00	$ 2,412.600 Million	2,000
Keenova Therapeutics Plc	1,191,250.00	$ 1,906.000 Million	1,600
Rigel Pharmaceuticals Inc	1,167,109.20	$ 203.077 Million	174
Biocryst Pharmaceuticals Inc	1,157,436.78	$ 503.485 Million	435
Heron Therapeutics Inc	1,155,132.81	$ 147.857 Million	128

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.